S.Korea approves Pfizer COVID-19 vaccine for children aged 5-11

1 minute read

A nurse fills a syringe with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at a vaccination centre in Seoul, South Korea March 20, 2021. Jung Yeon-je/Pool via REUTERS

Register now for FREE unlimited access to Reuters.com

SEOUL, Feb 23 (Reuters) - South Korea has approved Pfizer's (PFE.N) COVID-19 vaccine for use with children aged 5-11, the country's food and drug ministry said on Wednesday.

Children should get one-third of the regular dose, twice with a three week interval, the ministry said in a statement. Children with significantly declined immunity can get a booster four weeks later.

Register now for FREE unlimited access to Reuters.com
Reporting by Josh Smith

Our Standards: The Thomson Reuters Trust Principles.